Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

inhaled voriconazole

An inhaled formulation of voriconazole, a synthetic triazole with antifungal activity. Upon administration by inhalation, voriconazole selectively inhibits 14-alpha-lanosterol demethylation in fungi, preventing the production of ergosterol, an essential constituent of the fungal cell membrane, and resulting in fungal cell lysis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	ZP 059 ZP-059 ZP059

inhaled voriconazole

Search NCI's Drug Dictionary